Delivery Order SPE2DB22D3301-SPE2DB24FZ2ES

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,098.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of CONCERTA ER 18 MG TABLET 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 19, 2024. The contract is not set aside for any specific business category. AmerisourceBergen is a major supplier of pharmaceutical...
This federal contract award, valued at $11,892.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4565441110 CONCERTA ER 18 MG TABLET 100S. The award has an ultimate completion date of August 14, 2024 and is a Firm Fixed Price contract. This contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with government...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,522.63, is a delivery order for the supply of CONCERTA ER 18 MG TABLET 100S. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,513.92, is for the delivery of CONCERTA ER 18 MG TABLET 100S. It is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,478.11, is for the delivery of CONCERTA ER 36 MG TABLET 100S, a prescription medication. The contract has a firm fixed price and a completion date of November 20, 2024. This award is a delivery order contract and was not designated as a set-aside. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,598.97 fixed-price delivery order is for the supply of CONCERTA ER 18 MG TABLET 100S, a medication used to treat ADHD. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,124.75 firm fixed-price delivery order is for the supply of CONCERTA ER 18 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,251.36 contract is a firm fixed-price delivery order for CONCERTA ER 18 MG TABLET 100S, a prescription medication. The contract has a completion date of June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Concerta ER 18 mg tablets. The contract, valued at $10,178.49, is a firm fixed price Delivery Order with an ultimate completion date of August 20, 2024. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, which enable efficient procurement of a wide range of pharmaceutical...
This federal contract award, valued at $10,131.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of 4564755300 - CONCERTA ER 18 MG TABLET 100S. The contract has an ultimate completion date of May 31, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2ES
    Delivery Order

This federal contract award, valued at $3,366.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of CONCERTA ER 18 MG TABLET 100S, a specialty medication. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, to provide a wide range of pharmaceutical and medical supplies to support various government healthcare programs and military treatment facilities nationwide. This contract is not designated as a set-aside.

Generated 11/4/24, 11:12 AM